Announcements Trials

Browse Landscape

Phase

Phase 1 7 Phase 2 3 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Triple Negative Breast Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Hereditary Sensory and Autonomic Neuropathies 1 Advanced HER2+Breast Cancer 1

Interventions

Leucovorin 22 Fluorouracil 22 Gemcitabine 21 Capecitabine 21 Paclitaxel 20 Docetaxel 20 Irinotecan 15 Carboplatin 15 Radiosurgery 14 Oxaliplatin 13 Cisplatin 13 Bevacizumab 13 Zoledronic Acid 12 pembrolizumab 11 Radiotherapy 11 Fulvestrant 11 palbociclib 9 Pemetrexed 9 Drug Therapy 9 130-nm albumin-bound paclitaxel 9 Surgical Procedures, Operative 7 Letrozole 7 Ibandronic Acid 7 abemaciclib 6 Trastuzumab 6 Prednisone 6 Vinorelbine 5 Folfox protocol 5 Floxuridine 5 Doxorubicin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasm Metastasis × Alpelisib × Clear all

NCT05501886 2026-02-10

VIKTORIA-1

Celcuity Inc

Phase 3 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡